Glytrin Met Tablet ER is a combination of Metformin and Teneligliptin, both of which are anti-diabetic medications. Glytrin Met Tablet ER is used to treat type II diabetes mellitus in people when diet, exercise, and other traditional medications do not result in sufficient blood glucose control.

Type 2 diabetes mellitus is a chronic condition characterized by unusually high blood glucose levels. It is caused by insufficient synthesis of the hormone insulin (made by the pancreas to metabolize glucose) in the body or by insufficient sensitivity of body cells to the activities of insulin.

Usage instructions-

• Glytrin Met Tablet ER is used as directed by your doctor. With food, you can take Glytrin Met Tablet ER.

How it works-

Glytrin Met Tablet ER is a combination of two diabetes medications, Metformin and Teneligliptin. It works by raising insulin synthesis, which helps to restore your body's proper insulin response, particularly in muscle and fatty tissues, decreasing your increased blood sugar levels.

Safety information-

Pregnancy

Glytrin Met Tablet ER is probably not safe to use during pregnancy. There are limited human studies, but animal studies have shown adverse effects on the developing baby. Consult your doctor.

Breastfeeding

It is probably not safe to breastfeed while taking Glytrin Met Tablet ER. Limited human data suggests that the drug may enter breast milk and cause harm to the baby.

Alcohol

It is not safe to take alcohol with Glytrin Met Tablet ER.

Driving

It is not known whether it is safe or not Glytrin Met Tablet ER in terms of driving. You should consult your doctor.

Kidney

Glytrin Met Tablet ER should be administered with caution to patients with kidney disease. Dose adjustments may be necessary. Please consult your doctor.

Liver

In individuals with liver disease, Glytrin Met Tablet ER dose adjustments may be required. If you have a liver condition or have any concerns, please consult your doctor.